Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis.
Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
Heart rate variability.
A nine-year population-based cohort study on the risk of multiple sclerosis in patients with optic neuritis.
Multiple sclerosis: CCSVI deconstructed and discarded.
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
The effect of exercise training on fitness in multiple sclerosis: A meta-analysis.
Discovery of Enhancers of the Secretion of Leukemia Inhibitory Factor for the Treatment of Multiple Sclerosis.
Effects of dextromethorphan on glial cell function: Proliferation, maturation, and protection from cytotoxic molecules.
PET in Multiple Sclerosis.
Costs of formal and informal home care and quality of life for patients with multiple sclerosis in sweden.
Cerebrospinal fluid ferritin-Unspecific and unsuitable for disease monitoring.
Cannabinoid modulation of neuroinflammatory disorders.
Multiple sclerosis.
Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects.
[Assessment of the size of the thalamus as a method for the evaluation of the activity of neurodegenerative process after the treatment with cerebrolisin in young patients with multiple sclerosis.]
TRAF2 is Upregulated in Relapsing-Remitting Multiple Sclerosis.
A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function.
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli.
Preferences of Patients With Multiple Sclerosis for Attributes of Disease Modifying Drugs In Decision-Making: A Nominal Group Technique And Best-Worst Scaling.
Multiple sclerosis affects skeletal muscle characteristics.
Pages
« first
‹ previous
…
510
511
512
513
514
515
516
517
518
…
next ›
last »